Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Mebazaa

Showing results (461-470 of 645) with videos related to

Pageof 65
Sort By:
Circulation. Heart Failure|July 3, 2025
Guideline-Directed Medical Therapy Use in the STRONG-HF TrialXiang Zhang, Beth Davison, Marianna Adamo, et al.
Intensive Care Medicine|May 17, 2018
Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injuryEtienne Gayat, Alexa Hollinger, Alain Cariou, et al.
European Journal of Heart Failure|April 8, 2017
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term RegistryOvidiu Chioncel, Mitja Lainscak, Petar M Seferovic, et al.
ESC Heart Failure|June 26, 2024
Optimizing heart failure pathways to enhance patient care: the Program to Optimize Heart Failure Patient Pathways (PRO-HF)Ashish Patwala, Diane Barker, Antoine Da Costa, et al.
The Lancet. Respiratory Medicine|July 10, 2021
Optimising clinical trials in acute myocardial infarction complicated by cardiogenic shock: a statement from the 2020 Critical Care Clinical Trialists WorkshopMattia Arrigo, Susanna Price, David A Baran, et al.
Burns : Journal of the International Society for Burn Injuries|October 17, 2018
Prediction of major adverse kidney events in critically ill burn patientsFrançois Dépret, Louis Boutin, Jiří Jarkovský, et al.
ESC Heart Failure|May 30, 2025
Celebrating a decade of the HFA young community: Achievements and future directions by the HFA Young CommitteeMateusz Sokolski, Emanuele Bobbio, Alberto Esteban-Fernandez, et al.
European Heart Journal. Acute Cardiovascular Care|November 16, 2020
Risk stratification scores for patients with acute heart failure in the Emergency Department: A systematic reviewÒscar Miró, Xavier Rossello, Elke Platz, et al.
European Journal of Heart Failure|August 3, 2010
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathyKaren Sliwa, Denise Hilfiker-Kleiner, Mark C Petrie, et al.
The Lancet. Respiratory Medicine|December 13, 2021
Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trialMahir Karakas, Ibrahim Akin, Christoph Burdelski, et al.
Pageof 65

Showing results (461-470 of 645) with videos related to

Sort By:
Pageof 65
Circulation. Heart Failure|July 3, 2025
Guideline-Directed Medical Therapy Use in the STRONG-HF TrialXiang Zhang, Beth Davison, Marianna Adamo, et al.
Intensive Care Medicine|May 17, 2018
Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injuryEtienne Gayat, Alexa Hollinger, Alain Cariou, et al.
European Journal of Heart Failure|April 8, 2017
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term RegistryOvidiu Chioncel, Mitja Lainscak, Petar M Seferovic, et al.
ESC Heart Failure|June 26, 2024
Optimizing heart failure pathways to enhance patient care: the Program to Optimize Heart Failure Patient Pathways (PRO-HF)Ashish Patwala, Diane Barker, Antoine Da Costa, et al.
The Lancet. Respiratory Medicine|July 10, 2021
Optimising clinical trials in acute myocardial infarction complicated by cardiogenic shock: a statement from the 2020 Critical Care Clinical Trialists WorkshopMattia Arrigo, Susanna Price, David A Baran, et al.
Burns : Journal of the International Society for Burn Injuries|October 17, 2018
Prediction of major adverse kidney events in critically ill burn patientsFrançois Dépret, Louis Boutin, Jiří Jarkovský, et al.
ESC Heart Failure|May 30, 2025
Celebrating a decade of the HFA young community: Achievements and future directions by the HFA Young CommitteeMateusz Sokolski, Emanuele Bobbio, Alberto Esteban-Fernandez, et al.
European Heart Journal. Acute Cardiovascular Care|November 16, 2020
Risk stratification scores for patients with acute heart failure in the Emergency Department: A systematic reviewÒscar Miró, Xavier Rossello, Elke Platz, et al.
European Journal of Heart Failure|August 3, 2010
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathyKaren Sliwa, Denise Hilfiker-Kleiner, Mark C Petrie, et al.
The Lancet. Respiratory Medicine|December 13, 2021
Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trialMahir Karakas, Ibrahim Akin, Christoph Burdelski, et al.
Pageof 65